Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy
Authors:
- 16 August 2008
- journal article
- research article
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 247 (1) , 21-26
Abstract
Background The development of diabetic retinopathy is associated with the duration of diabetes and HbA1c levels. However, the familial aggregation of diabetic retinopathy is consistent with genetic susceptibility. Recently, a –634C/G polymorphism in the vascular endothelial growth factor (VEGF) gene was shown to be associated with diabetic retinopathy. To clarify the contribution of the VEGF gene in the development of diabetic retinopathy we analyzed variants in this gene among 469 Japanese patients with type 2 diabetes. Methods DNA from each patient was typed for –634C/G and –2578C/A polymorphisms using conventional polymerase chain reaction techniques. The vitreous fluid samples were obtained from 40 patients with PDR for measurement of VEGF levels. Results We found a significantly higher frequency of the A allele in the group with proliferative diabetic retinopathy (PDR) than in the control group at –2578C/A polymorphism (p = 0.036). Moreover, if the subjects were grouped according to the duration of diabetes and status of diabetic retinopathy (a first group consisting of subjects with longer duration (>20 y) of diabetes without any retinopathy (n = 102), and a second group of those with shorter diabetes (n = 35), the genotype distribution at -2578 C/A polymorphism was again significantly higher in the second group (p = 0.005) and differed significantly (p = 0.002) in a recessive model. The risk of the AA for PDR was 7.7 (95%, CI: 1.8–30.9). Conclusions The AA genotype at –2578C/A polymorphism in the VEGF gene is associated with proliferative diabetic retinopathy. No significant association with –634 C/G polymorphism was confirmed.Keywords
This publication has 30 references indexed in Scilit:
- Genetic Polymorphisms of Vascular Endothelial Growth Factor and Angiopoietin 2 in Retinopathy of PrematurityCurrent Eye Research, 2006
- Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetesBiochemical and Biophysical Research Communications, 2005
- VEGF polymorphisms and severity of atherosclerosisJournal of Medical Genetics, 2005
- Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and PrognosisClinical Cancer Research, 2005
- Vascular endothelial growth factor gene variability is associated with increased risk for ADAnnals of Neurology, 2005
- VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancerLung Cancer, 2004
- Genetic polymorphism of VEGF: Impact on longitudinal change of peritoneal transport and survival of peritoneal dialysis patientsKidney International, 2004
- The pathogenesis of diabetic retinopathy: old concepts and new questionsEye, 2002
- Determination of probability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithmAnnals of Human Genetics, 2002
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998